Paper16632085
Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable.
Farrar JT and 2 others. J Pain Symptom Manage, 2006. Cited by 110 papers, by iCite.
Cite this record
ConductScience Library. Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable. Papers, record 16632085. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16632085
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Analgesics | Major topic |
| Outcome Assessment, Health Care | Major topic |
| Pain | Major topic |
| Clinical Trials as Topic | |
| Data Display | |
| Data Interpretation, Statistical | |
| Humans | |
| Pain Measurement |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| KO8-NS01865 | NINDS NIH HHS | United States | K08NS001865 | PubMed and NIH | NIH RePORTER |
| R01-CA73797 | NCI NIH HHS | United States | R01CA073797 | PubMed and NIH | NIH RePORTER |
| Z01DE000366 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 18655954 | Re: cumulative proportion of responders. | https://conductscience.org/library/papers/18655954 |
Source PubMed
Cited by51
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42501111 | Effects of Terminalia fagifolia mart. extract combined with photobiomodulation on diabetic foot ulcers: protocol for a randomized single-blind clinical trial. | Lasers Med Sci | 2026 | https://conductscience.org/library/papers/42501111 | PubMed |
| 41396210 | Dual-Polymer Carboxymethyl Cellulose and Poly(Ethylene Oxide) Gel Reduces Leg and Back Pain in Patients With Severe Leg and Back Pain Following Single-Level Partial Discectomy. | Spine (Phila Pa 1976) | 2026 | https://conductscience.org/library/papers/41396210 | PubMed |
| 41028567 | Dose-response and efficacy of 660-nanometer low-level laser therapy in healing diabetic foot ulcers: a randomized, double-blind, clinical trial. | Lasers Med Sci | 2025 | https://conductscience.org/library/papers/41028567 | PubMed |
| 41021046 | Dose-response and efficacy of 830-nanometer photobiomodulation in healing diabetic foot ulcers: randomized, double-blind, clinical trial protocol. | Lasers Med Sci | 2025 | https://conductscience.org/library/papers/41021046 | PubMed |
| 39137167 | Oral resveratrol in adults with knee osteoarthritis: A randomized placebo-controlled trial (ARTHROL). | PLoS Med | 2024 | https://conductscience.org/library/papers/39137167 | PubMed |
| 38805069 | Dose-response and efficacy of 904 nm photobiomodulation on diabetic foot ulcers healing: a randomized controlled trial. | Lasers Med Sci | 2024 | https://conductscience.org/library/papers/38805069 | PubMed |
| 37519369 | Comparison of false positive and false negative rates of two indices of individual reliable change: Jacobson-Truax and Hageman-Arrindell methods. | Front Psychol | 2023 | https://conductscience.org/library/papers/37519369 | PubMed |
| 37274016 | Statistical Evaluation of Absolute Change versus Responder Analysis in Clinical Trials. | Acta Mater Med | 2022 | https://conductscience.org/library/papers/37274016 | PubMed |
| 37231386 | Effectiveness of spinal manipulation and biopsychosocial self-management compared to medical care for low back pain: a randomized trial study protocol. | BMC Musculoskelet Disord | 2023 | https://conductscience.org/library/papers/37231386 | PubMed |
| 37205428 | Effectiveness of Spinal Manipulation and Biopsychosocial Self-Management compared to Medical Care for Low Back Pain: A Randomized Trial Study Protocol. | Res Sq | 2023 | https://conductscience.org/library/papers/37205428 | PubMed |
| 36766649 | The Immediate Hypoalgesic Effect of Low and High Force Thoracic Mobilizations in Asymptomatic Subjects as Measured by Pain Pressure Thresholds (PPT). | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/36766649 | PubMed |
| 36107505 | Fast pain relief in exercise-induced acute musculoskeletal pain by turmeric-boswellia formulation: A randomized placebo-controlled double-blinded multicentre study. | Medicine (Baltimore) | 2022 | https://conductscience.org/library/papers/36107505 | PubMed |
| 35669038 | The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients. | Front Pain Res (Lausanne) | 2022 | https://conductscience.org/library/papers/35669038 | PubMed |
| 35263346 | Outcomes of a controlled trial with visiting therapy dog teams on pain in adults in an emergency department. | PLoS One | 2022 | https://conductscience.org/library/papers/35263346 | PubMed |
| 35232482 | Multidisciplinary integrative care versus chiropractic care for low back pain: a randomized clinical trial. | Chiropr Man Therap | 2022 | https://conductscience.org/library/papers/35232482 | PubMed |
| 34534176 | An implantable restorative-neurostimulator for refractory mechanical chronic low back pain: a randomized sham-controlled clinical trial. | Pain | 2021 | https://conductscience.org/library/papers/34534176 | PubMed |
| 33521483 | Essential statistical principles of clinical trials of pain treatments. | Pain Rep | 2021 | https://conductscience.org/library/papers/33521483 | PubMed |
| 33470748 | Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendations. | Pain | 2021 | https://conductscience.org/library/papers/33470748 | PubMed |
| 32701836 | Efficacy and safety of propranolol for treatment of temporomandibular disorder pain: a randomized, placebo-controlled clinical trial. | Pain | 2020 | https://conductscience.org/library/papers/32701836 | PubMed |
| 32520773 | Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations. | Pain | 2020 | https://conductscience.org/library/papers/32520773 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16632085
GET https://conductscience.org/api/papers/v1/16632085/cited_by?page=2